(Q52847673)

8 May 2018

title

Prevention of chronic Pseudomonas aeruginosa infection in people with cystic fibrosis. (English)

1 reference

8 May 2018

main subject

Pseudomonas aeruginosa

0 references

author name string

Steven P Conway

series ordinal

1

1 reference

8 May 2018

Tim Wr Lee

series ordinal

2

1 reference

8 May 2018

publication date

1 August 2009

1 reference

8 May 2018

Expert Review of Respiratory Medicine

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

8 May 2018

volume

3

1 reference

8 May 2018

issue

4

1 reference

8 May 2018

page(s)

349-361

1 reference

8 May 2018

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

cites work

1 reference

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease

21 January 2018

1 reference

New concepts of the pathogenesis of cystic fibrosis lung disease

21 January 2018

1 reference

Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface

21 January 2018

1 reference

Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis

21 January 2018

1 reference

Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis.

21 January 2018

1 reference

Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis

21 January 2018

1 reference

Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis

21 January 2018

1 reference

Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis

21 January 2018

1 reference

Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition

21 January 2018

1 reference

Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.

21 January 2018

1 reference

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

21 January 2018

1 reference

Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

21 January 2018

1 reference

Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis

21 January 2018

1 reference

Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995).

21 January 2018

1 reference

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience

21 January 2018

1 reference

Predictors of mortality in adults with cystic fibrosis

21 January 2018

1 reference

Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.

21 January 2018

1 reference

Early intervention and prevention of lung disease in cystic fibrosis: a European consensus

21 January 2018

1 reference

Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center

21 January 2018

1 reference

Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients

21 January 2018

1 reference

Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

21 January 2018

1 reference

Patient cohorting and infection control

21 January 2018

1 reference

Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic.

21 January 2018

1 reference

Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients

21 January 2018

1 reference

Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.

21 January 2018

1 reference

Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.

21 January 2018

1 reference

Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic.

21 January 2018

1 reference

Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection

21 January 2018

1 reference

A laminar flow model of aerosol survival of epidemic and non-epidemic strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis

21 January 2018

1 reference

Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa.

21 January 2018

1 reference

Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients

21 January 2018

1 reference

A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance.

21 January 2018

1 reference

Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.

21 January 2018

1 reference

Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units

21 January 2018

1 reference

Cystic fibrosis patients and families support cross-infection measures

21 January 2018

1 reference

Segregation--the perspectives of young patients and their parents

21 January 2018

1 reference

Cross-infection in cystic fibrosis: the knowledge and behaviour of adult patients.

21 January 2018

1 reference

Barriers to adherence to cystic fibrosis infection control guidelines

21 January 2018

1 reference

Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients

21 January 2018

1 reference

Clinical value of obtaining sputum and cough swab samples following inhaled hypertonic saline in children with cystic fibrosis

21 January 2018

1 reference

Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism.

21 January 2018

1 reference

Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents

21 January 2018

1 reference

Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis

21 January 2018

1 reference

Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing.

21 January 2018

1 reference

Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors

21 January 2018

1 reference

Pseudomonas serology: confusion, controversy, and challenges

21 January 2018

1 reference

Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization

21 January 2018

1 reference

Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis

21 January 2018

1 reference

Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.

21 January 2018

1 reference

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

21 January 2018

1 reference

Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis

21 January 2018

1 reference

Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis

21 January 2018

1 reference

A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis

21 January 2018

1 reference

Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis

21 January 2018

1 reference

Bronchoconstriction following nebulised colistin in cystic fibrosis

21 January 2018

1 reference

Evaluation of bronchial constriction in children with cystic fibrosis after inhaling two different preparations of tobramycin

21 January 2018

1 reference

Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data

21 January 2018

1 reference

Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis

21 January 2018

1 reference

Mouthpiece versus facemask for delivery of nebulized salbutamol in exacerbated childhood asthma

21 January 2018

1 reference

Stenotrophomonas maltophilia contamination of nebulizers used to deliver aerosolized therapy to inpatients with cystic fibrosis.

21 January 2018

1 reference

Does repeated disinfection of the e-Flow rapid nebulizer affect in vitro performance?

21 January 2018

1 reference

Adherence to nebulised antibiotics in cystic fibrosis

21 January 2018

1 reference

A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients

21 January 2018

1 reference

Eradication of early Pseudomonas infection in cystic fibrosis

21 January 2018

1 reference

Cystic fibrosis mortality and survival in the UK: 1947-2003

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERS.09.26

1 reference

8 May 2018

1 reference

8 May 2018